James Cox files Form 144 reporting Common stock sales

James Cox submitted a Form 144 notice reporting proposed distributions of Common stock.

Rhea-AI Filing Summary

James Cox submitted a Form 144 notice reporting proposed distributions of Common stock. The filing lists securities to be sold on 03/16/2026 tied to an Exercise of Stock Options (13,700 shares) and Restricted Stock Units dated 02/21/2023 (5,000 shares). The filing also discloses prior 10b5-1 sales, including 93,930 shares for $2,201,878.88 on 02/18/2026 and other dated sales shown in the excerpt.

Insights

Securities Compliance Lawyer

Form 144 notifies the SEC of proposed affiliate sales and lists recent 10b5-1 transactions.

The notice enumerates specific security lots: an Exercise of Stock Options for 13,700 shares dated 03/16/2026 and Restricted Stock Units for 5,000 shares dated 02/21/2023. It also records multiple completed sales under a 10b5-1 sales plan, including 93,930 shares for $2,201,878.88 on 02/18/2026.

These entries serve as statutory disclosure for affiliate dispositions. Cash‑flow treatment and any broker or purchaser identities are not shown in the provided excerpt; subsequent filings or broker reports would provide settlement details if required.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does James Cox's Form 144 for CWAN report?

The filing reports proposed sales of Common stock, listing 13,700 shares tied to an Exercise of Stock Options on 03/16/2026 and 5,000 RSUs dated 02/21/2023. It also lists recent 10b5-1 sales and proceeds amounts.

Which recent 10b5-1 sale amounts are disclosed in the Form 144 excerpt?

The excerpt shows multiple 10b5-1 sales, notably 93,930 shares for $2,201,878.88 on 02/18/2026, plus other sales on 02/17/2026, 01/15/2026, and end‑of‑year entries with proceeds listed alongside each date.

Does the Form 144 state who will receive proceeds from the sales for CWAN?

The provided excerpt does not specify payee details beyond the reporting party name, James Cox. The filing lists proceeds per sale (dollar amounts) but does not identify intermediary brokers or final recipients in this excerpt.

Are the shares listed from option exercise or vested awards in this Form 144?

Yes. The filing lists an Exercise of Stock Options dated 03/16/2026 for 13,700 shares and Restricted Stock Units dated 02/21/2023 for 5,000 shares, both shown under the securities to be sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:36 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001441361
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Clearwater Analytics Holdings, Inc.
SEC File Number	001-40838
Address of Issuer	777 W. Main Street, Suite 900 Boise IDAHO 83702
Phone	2084331200
Name of Person for Whose Account the Securities are To Be Sold	JAMES COX
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	18700	433279.00	294353077	03/16/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	Exercise of Stock Options	Issuer			13700	03/16/2026	Cash
Common	02/21/2023	Restricted Stock Units	Issuer			5000	02/21/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	02/18/2026	93930	2201878.88
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	02/17/2026	18700	429404.54
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	01/15/2026	18700	451440.48
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	01/01/2026	63709	1534909.08
JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/31/2025	5859	141105.81
10b5-1 Sales Plan for JAMES COX 777 W. Main Street, Suite 900 Boise ID 83702	Common	12/17/2025	7425	163350.00

144: Remarks and Signature

Remarks
Date of Notice	03/16/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/11/2024
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James Cox
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)